NCT07311746
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Refractory T-Cell Prolymphocytic Leukemia
Explore clinical trials studying Refractory T-Cell Prolymphocytic Leukemia. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study